142Nd Meeting of the Board of Directors 10.30Am, Thursday 5 Nov 2020 by Web-Ex AGENDA
Total Page:16
File Type:pdf, Size:1020Kb
142nd Meeting of the Board of Directors 10.30am, Thursday 5 Nov 2020 By Web-ex AGENDA ITEM Purpose Presented by Category Time General business 5 mins Apologies for absence and To receive and record apologies for declaration of any conflicts of Andy Trotter 1 absence and request and record any Governance interest Chair declarations of interest • Azara Mukhtar (apologies) Minutes of the Board of To approve the minutes of the last Andy Trotter 2 Directors’ Meeting held on 3 Governance meeting Chair p4 September 2020 To confirm actions allocated at Matters arising Andy Trotter 3 previous meetings have been Governance • Board Actions Tracker Chair p12 completed To accept the BAF and consider whether the framework continues to Andy Trotter 4 Board Assurance Framework Governance provide sufficient assurance to the Chair p14 board Governance and Strategy 90 mins To note the developments within the Matthew Trainer, 5 Chief Executive Report trust and in the local health Strategy Chief Executive p22 economy. Matthew Trainer, Chief Executive/ Abi Fadipe, Deputy Medical Director/Lorraine To discuss and agree the strategy 6 Oxleas Strategy - presentation Regan, Service Strategy proposals p25 Director/ Rachel Clare Evans, Director of Strategy and People Iain Dimond, Operational update and Quality and 7 To note the update Chief Operating integrated performance report Performance p26 Officer Michael Witney, Pre Admission Suite inquiry report To note the report and agree future 8 Director of Governance – progress update oversight process p79 Therapies Jane Wells, To note the reports and consider any 9 RW incident report Director of Governance implications p92 Nursing Jane Wells, To note the reports and consider any 10 Mortality Surveillance Report Director of Governance implications p94 Nursing Page 1 of 3 142nd Meeting of the Board of Directors 10.30am, Thursday 5 Nov 2020 By Web-ex AGENDA Ify Okocha, 11 Quality Account To approve the report Governance Medical Director p103 Ify Okocha, 12 Quality Management Framework To approve the proposed approach Governance p160 Medical Director Michael Witney, Patient experience of virtual To note the reports and consider any 13 Director of Strategy consultations implications p179 Therapies The Workforce Disability Equality Rachel Clare Standard (WDES) and Workforce To approve the action plans and Evans, Director of 14 Race Equality Standard (WRES) Governance report and consider any implications Strategy and action plans and Equality annual p265 People report Committee reports 20 mins Performance and Quality Yemisi Gibbons, To note the contents of the report Quality and 15 Assurance Committee Non Executive and agree any strategic implications performance p303 • Complaints annual report Director Amlan Basu, Quality Improvement and To note the contents of the report Quality and 16 Non Executive Innovation Committee and agree any strategic implications performance p318 Director Jo Stimpson, To note the contents of the report Financial strategy 17 Business Committee Non Executive and agree any strategic implications and performance p322 Director Jo Stimpson, To note the contents of the report Strategic 18 Partnership Committee Non Executive and agree any strategic implications partnerships p344 Director Suzanne Shale, To note the contents of the report Strategy and 19 Infrastructure Committee Non Executive and agree any strategic implications performance p346 Director Nina Hingorani- Workforce Committee To note the contents of the report Crain, 20 • Freedom to Speak Up People strategy and agree any strategic implications Non Executive p352 summary report Director To note the contents of the report Steve Dilworth 21 Audit and Risk Assurance report and approve the risk appetite Non Executive Governance p355 framework Director Nominations Committee for Andy Trotter, 22 Executive Board Director To note the contents of the report Governance Chair p369 appointments report Page 2 of 3 142nd Meeting of the Board of Directors 10.30am, Thursday 5 Nov 2020 By Web-ex AGENDA Board reports 15 mins Information relating to the experience of staff and patients and Andy Trotter Quality and staff 23 Board visits reports p370 assess impact on delivery of trust Chair engagement objectives Andy Trotter Council of Governors update and To note the contents of the report Chair/ 24 proposals for changes to the and approve the proposed changes Governance Sally Bryden, p382 Constitution to the Trust Constitution Trust Secretary Board committee development Sally Bryden, 25 To approve the paper and structure Governance p387 report Trust Secretary ANY OTHER BUSINESS REVIEW EFFECTIVENESS OF MEETING DATE OF NEXT MEETING The next Board of Directors Meeting will take place on: Thursday 14 January at 10.30am Page 3 of 3 Board of Directors Item 2 5 November 2020 Enclosure 2 Report Title Minutes of the Board of Directors Meeting held on 3 September 2020 Author Susan Owen, Risk and Governance Manager Accountable Director Andy Trotter, Chair Confidentiality/ Public FOI status Report Summary Minutes of the Board of Directors meeting held on 3 September 2020 Purpose (To select purpose, Information To Note click on relevant choice for drop down box) Approval √ Decision Recommendation The Board agrees the minutes as a true record of the meeting. Link to strategic objectives Quality Workforce Sustainability Partnerships (click on relevant choice for drop down box) Link to Board N/A Assurance Framework Implications Quality Financial Equality analysis Service user/carer/staff 141st Meeting of the Board of Directors Minutes of the meeting held on Thursday 3 September 2020 Virtual meeting held via MS Teams Board of Directors Andy Trotter Trust Chair Steve Dilworth Non-executive Director Nina Hingorani-Crain Non-executive Director Steve James Non-executive Director Jo Stimpson Non-executive Director Suzanne Shale Non-executive Director Dr Amlan Basu Non-executive Director Yemisi Gibbons Non-executive Director Matthew Trainer Chief Executive Iain Dimond Chief Operating Officer Dr Ify Okocha Medical Director Jane Wells Director of Nursing Dr Michael Witney Director of Therapies Rachel Evans (RCE) Director for Strategy and People Azara Mukhtar Interim Director of Finance In attendance Sally Bryden Trust Secretary and Associate Director of Corporate Affairs Tom Clark Deputy Medical Director Abi Fadipe Deputy Medical Director Alison Furzer Director of Informatics Susan Owen Risk and Governance Manager (minutes) Members of the Council of Governors in attendance Sue Hardy Public: Bexley Sue Read Staff: Bexley adult services Item Subject Action 1 Apologies for absence Noted • None received. Declarations of interest • None raised. 2 Minutes of last meeting Approved Page 1 – Amend action to read as: “An update on health and safety will be discussed at the Workforce Committee and potentially at a future Board Strategy Day.” Item 8 – Amend SS’s comment to read: “I understand Victoria Ellis is in the process of developing a revised quality management framework, and a revised approach may help with addressing issues around spread of learning.” Item 9 – Amend to narrative to read as: “The number of cases are lower than for the same period last year, but the Staff Partnership Team took a slightly different approach involving team discussions. The new service is confident that we are achieving a good level of cases, but we will continue to raise their profile.” Item 10 – Amend SS’s comment to read as: “…if we do not do this, we will not be ensuring the charitable funds are used to fulfil the purpose for which they were given.” Pending these amendments, the minutes of the meeting on 2 July 2020 were approved as an accurate record. 3 Matters arising Noted No matters arising. Page 1 of 7 Item Subject Action 4 Board Assurance Framework and Covid-19 risks Noted The board noted the Board Assurance Framework and Covid-19 risk register. MT said that in relation to risk ID 1709 (responding to service delivery concerns), the trust has received a number of questions from the CQC and complaints have been raised with them some of which are multiple concerns raised by a small number of people. The Quality Assurance Team have worked hard to respond to these, and a detailed paper will be presented to the executive team and the Performance and Quality Assurance Committee. MT said that our strategic risks are likely to be re-shaped over the coming months. AM said that no specific risk issues have been identified from the Transformation Programme Executive Group. The Covid-19 finance risk remains unchanged for the present, and the future of this risk is predicated on the month 7 outcome. SS – Those comments have addressed my observations. I am interested to know the risks that we will need to focus on in the next months. At the November meeting, it would helpful to have this conversation and take stock. AT – We will ask the executive to consider how to take this forward. JS – Periodically, the leadership group could review our organisational risks and how we refresh these. AB – For risk ID 1875 (impact of Covid-19 on service delivery, are we truly confident that scaling back services has not affected patient outcomes and experience? ID – This risk was written at a particular point in time. The directorate operational reviews have identified that there are legacy issues which are impacting on services. We will re- articulate the risk for the current situation. 5 Chief Executive Report Noted MT presented the Chief Executive Report. The trust is returning to pre-Covid-19 levels of service, in addition to managing a backlog, and preparing for usual winter pressures. There will be additional local impacts relating to the re-opening of schools. The trust is in a good position to take advantage of the strength of communication across the teams, and learning at ICS level. District nursing teams are experiencing a high level of demand, and we will need to respond to this. We recognise that there may be some actions as a result of the recent CQC inspection of CMHTs.